Pharmaceutical Industry News Archive

Get news By email or subscribe to our News feeds.

October 2009

October 5

Seattle Genetics Announces Discontinuation of Dacetuzumab Phase IIb Diffuse Large B-Cell Lymphoma Clinical Trial Pharmaceutical Companies Rebrand Speaker Programs to Meet Changing Political and Regulatory Landscape, Says New Study by Cutting Edge Information SEC Closes Investigation of PharmaNet Development Group and Recommends No Action Daiichi Sankyo to Leverage Ranbaxy's Presence in Mexico for Marketing and Distribution Physician Smartphone Adoption Rate to Reach 81% in 2012 License to Market Kremezin (drug for chronic renal failure) in Japan CombinatoRx-Derived Combination Drug Candidate, Prednisporin, Acquired by Sanofi-Aventis Through Proposed Acquisition of Fovea Pharmaceuticals Phase 2 Trial Of Rp101 In Late-Stage Pancreatic Cancer Discontinued In the battle against cancer, ?future progress depends on personalisation of healthcare? says AstraZeneca Chief Executive

October 14

FDA Acts to Halt Marketing of Unapproved Codeine Sulfate Tablets Dainippon Sumitomo Pharma Co., Ltd. and Sepracor Inc. Announce Successful Tender Offer and Commencement of Subsequent Offering Period Acorda Therapeutics Stock Trading Halted Today; FDA Advisory Committee to Review Fampridine-SR for Improvement of Walking Ability in People with Multiple Sclerosis Elan Corporation PLC Announces Results to Date of Tender Offer for 7¾% Senior Fixed Rate Notes Due 2011 Pfizer Announces Settlement And License Agreement With Mylan Related To Vfend Abbott Reports 16.5 Percent Earnings Growth in Third Quarter; Raises Earnings Guidance for 2009 Galapagos Expands Strategic Alliance in Metabolic Disease with Merck & Co., Inc. CSL Donates 3 Million Doses of Pandemic H1N1 2009 Vaccine to the World Health Organisation (WHO) for Use in Low-Income Countries in this Region Sample Accountability Shows Stepped-Up Focus
(web5)